Alligator Bioscience AB (ATORX.XSTO) Financials
All currency values in kr millions unless otherwise noted
Scroll
| Income Statement | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | kr 1 | kr 58 | kr 58 | kr 36 | kr 13 |
| Operating Income | -kr 122 | -kr 190 | -kr 231 | -kr 192 | -kr 143 |
| Non-Operating | |||||
| Net Interest Expense | -kr 44 | -kr 20 | -kr 20 | -kr 1 | -kr 0 |
| Income Tax Expense | kr 0 | kr 0 | kr 0 | kr 0 | kr 0 |
| Net Income | |||||
| Net Income | -kr 51 | -kr 234 | -kr 234 | -kr 193 | -kr 142 |
| Per Share Data | |||||
| Revenue Per Share | kr 0.02 | kr 3.25 | kr 0.08 | kr 0.16 | kr 0.09 |
| EPS (Basic) | -kr 1.87 | -kr 13.16 | -kr 0.32 | -kr 0.88 | -kr 0.96 |
| EPS (Diluted) | -kr 1.87 | -kr 13.16 | -kr 0.32 | -kr 0.88 | -kr 0.96 |
| Shares Outstanding | 27.5M | 17.8M | 730.9M | 219.8M | 148.0M |
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.